IMT stands for Intelligence in Medical Technology
We identify people's cardiovascular risk with a disruptive test, establish their vascular age, & allow to save MI and strokes by earlier preventive therapies.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Paris, France
- Currency USD
- Founded January 2015
- Employees 4
- Website iimt.fr
Company Summary
We identify individual cardiovascular (CV) risk and establish people's vascular age with increased predictive value, allowing earlier preventive therapies & contributing to saving lives.
With an ultrasound exam, M’Ath® characterizes the CV risk (stroke and heart attack) with 2 predictive markers: Carotid intima media thickness (CIMT), and total plaque area (CTPA).
Completing the current practice, we reduce wrong "low risk" diagnosis by 50%.
Team
-
Vascular neurologist and professor; inventor & conceiver of the solutions; worldwide expert on atherosclerosis; author of numerous publications on primary and secondary prevention of cardiovascular clinical events, and of the international consensus on the carotid ultrasound examinations.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.